$CCLD
CareCloud, Inc. Stock $ccld

$ccld Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223015456 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$29.36M	$30.00M	$35.34M
YoY Change	-21.13%	-15.11%	18.71%
Cost Of Revenue	$17.48M	$18.11M	$22.67M
YoY Change	-19.77%	-20.13%	25.54%
Gross Profit	$11.89M	$11.89M	$12.67M
YoY Change	-23.0%	-6.14%	8.18%
Gross Profit Margin	40.49%	39.63%	35.85%
Selling, General & Admin	$8.496M	$7.732M	$7.969M
YoY Change	-3.67%	-2.97%	6.11%
% of Gross Profit	71.46%	65.03%	62.91%
Research & Development	$1.185M	$1.078M	$985.0K
YoY Change	7.92%	9.44%	-51.48%
% of Gross Profit	9.97%	9.07%	7.78%
Depreciation & Amortization	$3.450M	$3.210M	$3.080M
YoY Change	12.05%	4.22%	4.41%
% of Gross Profit	29.02%	27.0%	24.31%
Operating Expenses	$30.65M	$30.22M	$11.89M
YoY Change	-11.09%	154.11%	-3.85%
Operating Profit	-$1.289M	-$223.0K	$774.0K
YoY Change	-146.8%	-128.81%	-217.27%
Interest Expense	-$280.0K	-$130.0K	-$95.00K
YoY Change	169.23%	36.84%	58.33%
% of Operating Profit			-12.27%
Other Income/Expense, Net	-$186.0K	$17.00K	$83.00K
YoY Change	-266.07%	-79.52%	-137.73%
Pretax Income	-$1.750M	-$336.0K	$1.204M
YoY Change	-163.36%	-127.91%	-161.12%
Income Tax	$82.00K	$65.00K	$64.00K
% Of Pretax Income			5.32%
Net Earnings	-$1.832M	-$401.0K	$1.140M
YoY Change	-166.93%	-135.18%	-158.04%
Net Earnings / Revenue	-6.24%	-1.34%	3.23%
Basic Earnings Per Share	-$0.37	-$0.28	-$0.19
Diluted Earnings Per Share	-$0.37	-$0.28	$76.04K
COMMON SHARES
Basic Shares Outstanding	15.59M shares	15.51M shares	14.99M shares
Diluted Shares Outstanding	15.62M shares	15.42M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.700M	$8.200M	$9.136M
YoY Change	-16.49%	-10.25%	-56.5%
Cash & Equivalents	$7.666M	$8.161M	$10.14M
Short-Term Investments
Other Short-Term Assets	$2.900M	$3.400M	$4.050M
YoY Change	-33.1%	-16.05%	-42.96%
Inventory	$402.0K	$265.0K	$417.0K
Prepaid Expenses
Receivables	$12.02M	$14.65M	$23.14M
Other Receivables	$0.00	$0.00	$16.00K
Total Short-Term Assets	$27.82M	$31.48M	$36.76M
YoY Change	-26.08%	-14.36%	-18.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.747M	$4.520M	$11.90M
YoY Change	-2.12%	-62.03%	-4.01%
Goodwill
YoY Change
Intangibles	$27.92M	$28.54M
YoY Change	-7.47%
Long-Term Investments
YoY Change
Other Assets	$737.0K	$838.0K	$882.0K
YoY Change	-8.67%	-4.99%	-32.15%
Total Long-Term Assets	$99.02M	$99.54M	$104.5M
YoY Change	-3.36%	-4.7%	13.3%
TOTAL ASSETS
Total Short-Term Assets	$27.82M	$31.48M	$36.76M
Total Long-Term Assets	$99.02M	$99.54M	$104.5M
Total Assets	$126.8M	$131.0M	$141.2M
YoY Change	-9.47%	-7.22%	2.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.179M	$5.191M	$5.833M
YoY Change	2.62%	-11.01%	24.11%
Accrued Expenses	$3.933M	$3.728M	$12.66M
YoY Change	-12.23%	-70.55%	-23.28%
Deferred Revenue	$1.242M	$1.394M	$1.140M
YoY Change	-14.34%	22.28%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$100.0K	$95.00K
YoY Change	-100.0%	5.26%	-52.5%
Total Short-Term Liabilities	$19.61M	$19.20M	$28.10M
YoY Change	-25.13%	-31.66%	2.93%
LONG-TERM LIABILITIES
Long-Term Debt	$10.00M	$10.00M	$6.018M
YoY Change	42.53%	66.17%
Other Long-Term Liabilities	$3.100M	$3.200M	$4.319M
YoY Change	-15.81%	-25.91%	-21.47%
Total Long-Term Liabilities	$13.10M	$13.20M	$10.34M
YoY Change	22.45%	27.7%	87.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.61M	$19.20M	$28.10M
Total Long-Term Liabilities	$13.10M	$13.20M	$10.34M
Total Liabilities	$33.31M	$32.94M	$38.92M
YoY Change	-10.85%	-15.37%	14.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.04M	-$26.21M
YoY Change	3.18%
Common Stock	$16.00K	$16.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$662.0K	$662.0K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$93.52M	$98.08M	$102.3M
YoY Change
Total Liabilities & Shareholders Equity	$126.8M	$131.0M	$141.2M
YoY Change	-9.47%	-7.22%	2.78%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.832M	-$401.0K	$1.140M
YoY Change	-166.93%	-135.18%	-158.04%
Depreciation, Depletion And Amortization	$3.450M	$3.210M	$3.080M
YoY Change	12.05%	4.22%	4.41%
Cash From Operating Activities	$6.390M	$1.023M	$3.087M
YoY Change	26.81%	-66.86%	221.56%
INVESTING ACTIVITIES
Capital Expenditures	$3.040M	$835.0K	-$2.797M
YoY Change	-207.42%	-129.85%	25.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.040M	-$3.039M	-$2.797M
YoY Change	7.42%	8.65%	25.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.040M	-$1.787M	-342.0K
YoY Change	130.2%	422.51%	-129.48%
NET CHANGE
Cash From Operating Activities	6.390M	$1.023M	3.087M
Cash From Investing Activities	-3.040M	-$3.039M	-2.797M
Cash From Financing Activities	-4.040M	-$1.787M	-342.0K
Net Change In Cash	-690.0K	-$4.138M	-52.00K
YoY Change	-251.98%	7857.69%	-48.0%
FREE CASH FLOW
Cash From Operating Activities	$6.390M	$1.023M	$3.087M
Capital Expenditures	$3.040M	$835.0K	-$2.797M
Free Cash Flow	$3.350M	$188.0K	$5.884M
YoY Change	-57.43%	-96.8%	85.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001582982
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2023Q1	CCLD	Issuance Of Stock Under Equity Incentive Plan IssuanceOfStockUnderEquityIncentivePlan		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q1	CCLD	Issuance Of Stock Under Equity Incentive Plan IssuanceOfStockUnderEquityIncentivePlan		usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2022	CCLD	Allowance For Doubtful Accounts Adoption AllowanceForDoubtfulAccountsAdoption		usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries		usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36529
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CareCloud, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3832302
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7 Clyde Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Somerset
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08873
CY2023Q1	dei	City Area Code CityAreaCode	(732)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	873-5133
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15592608	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8161000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12299000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14646000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14773000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5018000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4399000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	265000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	381000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3371000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2785000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	31477000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	34653000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4520000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5056000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4465000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4921000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28535000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29520000	usd
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	61186000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	61186000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	838000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	838000	usd
CY2023Q1	us-gaap	Assets Assets	131021000	usd
CY2022Q4	us-gaap	Assets Assets	136174000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5191000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5681000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2597000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4248000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3728000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4432000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2095000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2273000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1394000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1386000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	84000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	319000	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	4115000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	4059000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	19204000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22398000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	12000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	13000	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	10000000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	8000000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2822000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3207000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	350000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	342000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	551000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	525000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	32939000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	34485000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	6000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16333407	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15970204	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15592608	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15229405	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	129678000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	130987000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26208000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25621000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4748000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3037000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	740799	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	740799	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	662000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	662000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98082000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	101689000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	131021000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	136174000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30001000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35341000	usd
CY2023Q1	CCLD	Operating Costs OperatingCosts	18107000	usd
CY2022Q1	CCLD	Operating Costs OperatingCosts	22673000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2612000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2384000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5120000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5585000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1078000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	985000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-600000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3038000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2940000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	269000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	158000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	30224000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	34125000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-223000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1216000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	20000	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	5000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	150000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	100000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	83000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-336000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1204000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	65000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-401000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1140000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3931000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4037000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4332000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2897000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15421096	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14992147	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-401000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1140000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1711000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-255000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2112000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	885000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	101689000	usd
CY2023Q1	CCLD	Stock Issued During Period Value Cumulative Effect Of Adoption StockIssuedDuringPeriodValueCumulativeEffectOfAdoption	-186000	usd
CY2023Q1	CCLD	Stockholders Equity After Adoption StockholdersEquityAfterAdoption	101503000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-401000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1711000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1185000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1437000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3931000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98082000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	97931000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	97931000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1140000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1140000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-255000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	887000	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-20000000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	26638000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	11000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4037000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	102293000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	102293000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-401000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1140000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3205000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3080000	usd
CY2023Q1	CCLD	Amortization Of Lease AmortizationOfLease	683000	usd
CY2022Q1	CCLD	Amortization Of Lease AmortizationOfLease	832000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	16000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	104000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	97000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	131000	usd
CY2023Q1	CCLD	Provision Benefit For Deferred Income Taxes ProvisionBenefitForDeferredIncomeTaxes	26000	usd
CY2022Q1	CCLD	Provision Benefit For Deferred Income Taxes ProvisionBenefitForDeferredIncomeTaxes	36000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	11000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	52000	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	166000	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	168000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	6000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1072000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	887000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-600000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	156000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1618000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	619000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-80000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-116000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-86000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	615000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	97000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2556000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-1084000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1023000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3087000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	835000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	544000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	2204000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	2253000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3039000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2797000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3875000	usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3943000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1113000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	775000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	236000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	251000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	11000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1437000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	26638000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	20000000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	12700000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	8500000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10700000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10500000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1787000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-342000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-335000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-152000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4138000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-204000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12299000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10340000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8161000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10136000	usd
CY2023Q1	CCLD	Dividends Declared Not Paid DividendsDeclaredNotPaid	4115000	usd
CY2022Q1	CCLD	Dividends Declared Not Paid DividendsDeclaredNotPaid	3950000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	75000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	40000	usd
CY2023Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_801_eus-gaap--BasisOfAccounting_zuBEDjnQg8D9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-transform: uppercase; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <span id="xdx_822_ztLY0c7OvAia">BASIS OF PRESENTATION</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and as required by Regulation S-X, Rule 8-03. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of items of a normal and recurring nature) necessary to present fairly the Company’s financial position as of March 31, 2023, the results of operations for the three months ended March 31, 2023 and 2022 and cash flows for the three months ended March 31, 2023 and 2022. When preparing financial statements in conformity with GAAP, the Company must make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2022, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 2, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zD4XemcLz5Jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zxcvzJOj2Cr2">Recent Accounting Pronouncements</span></i></b> — From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) and are adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently adopted and recently issued accounting pronouncements will not have a material impact on our consolidated financial position, results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, <i>Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments. </i>The guidance in Accounting Standards Update (“ASU”) 2016-13 replaces the incurred loss impairment methodology under current GAAP. The new impairment model requires immediate recognition of estimated credit losses expected to occur for most financial assets and certain other instruments. It will apply to all entities. For trade receivables, loans and held-to-maturity debt securities, entities will be required to estimate lifetime expected credit losses. This may result in the earlier recognition of credit losses. In November 2019, the FASB issued ASU No. 2019-10, which delays this standard’s effective date for SEC smaller reporting companies to the fiscal years beginning on or after December 15, 2022. The Company adopted this guidance on January 1, 2023 using a modified retrospective adoption methodology, whereby the cumulative impact of all prior periods is recorded in accumulated deficit or other impacted balance sheet items upon adoption. The impact to the accumulated deficit as of January 1, 2023 for the allowance related to accounts receivable was a charge of approximately $<span id="xdx_90E_ecustom--AllowanceForDoubtfulAccountsAdoption_c20221230__20230102_zmBaHNFiV166" title="Allowance for accounts receivable">186,000</span> and a corresponding increase to the allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2020, the FASB issued ASU 2020-04 to simplify the accounting for contract modifications made to replace LIBOR or other reference rates that are expected to be discontinued because of reference rate reform. The guidance provides optional expedients and exceptions for applying U.S. GAAP to these contract modifications if certain criteria are met. The optional expedients and exceptions can be applied to contract modifications made until December 31, 2022. There was no impact on the consolidated financial statements as a result of this standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, <i>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40).</i> This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The Company adopted this guidance effective January 1, 2022. There was no impact on the consolidated financial statements as a result of this standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, <i>Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.</i> The amendments in this update require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. The amendments are effective for public business entities for fiscal years beginning after December 15, 2022. There was no impact on the consolidated financial statements as a result of this standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01, <i>Leases (Topic 842): Common Control Arrangements – Issue 2.</i> The amendments in this update require that leasehold improvements associated with common control leases be: (1) amortized by the lessee over the useful life of the leasehold improvements to the common control group as long as the lessee controls the use of the underlying asset through a lease and (2) accounted for as a transfer between entities under common control through an adjustment to equity if, and when, the lessee no longer controls the use of the underlying asset. The amendments in this update are effective for fiscal years beginning after December 15, 2023. The Company does not expect this update to have a material impact on the consolidated financial statements.</span></p> <p id="xdx_855_zOQ09lgfvxz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	CCLD	Allowance For Doubtful Accounts Adoption AllowanceForDoubtfulAccountsAdoption	186000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	61186000	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	61186000	usd
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	61186000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	61186000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	80207000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	78795000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51672000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	49275000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28535000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29520000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2500000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2500000	usd
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	10338000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9498000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6254000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1395000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	300000	usd
CY2023Q1	CCLD	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	750000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28535000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4332000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2897000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15421096	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14992147	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	10000000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	8000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	100000	usd
CY2023Q1	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	1400000	usd
CY2022Q4	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	1800000	usd
CY2023Q1	CCLD	Lease Term Description LeaseTermDescription	Leases with a term of less than 12 months are not recorded in the consolidated balance sheets.
CY2023Q1	CCLD	Unoccupied Lease Charges UnoccupiedLeaseCharges	153000	usd
CY2022Q1	CCLD	Unoccupied Lease Charges UnoccupiedLeaseCharges	263000	usd
CY2022Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	105000	usd
CY2023Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	71000	usd
CY2023Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	45000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	801000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	972000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	40000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	5000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	9000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	806000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	1021000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4465000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4921000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2095000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2273000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2822000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3207000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4917000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5480000	usd
CY2023Q1	CCLD	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	5207000	usd
CY2022Q4	CCLD	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	8293000	usd
CY2023Q1	CCLD	Asset Lease Expense AssetLeaseExpense	-683000	usd
CY2022Q4	CCLD	Asset Lease Expense AssetLeaseExpense	-3286000	usd
CY2023Q1	CCLD	Foreign Exchange Gain Loss ForeignExchangeGainLoss	-59000	usd
CY2022Q4	CCLD	Foreign Exchange Gain Loss ForeignExchangeGainLoss	-86000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4465000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4921000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.101	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079	pure
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	907000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	1212000	usd
CY2023Q1	CCLD	Right Of Use Asset Obtained In Exchange For Operating Leases Liability RightOfUseAssetObtainedInExchangeForOperatingLeasesLiability	287000	usd
CY2022Q1	CCLD	Right Of Use Asset Obtained In Exchange For Operating Leases Liability RightOfUseAssetObtainedInExchangeForOperatingLeasesLiability	427000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2057000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1661000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	952000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	323000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	229000	usd
CY2023Q1	CCLD	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1643000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6865000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1948000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4917000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2095000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2822000	usd
CY2023Q1	CCLD	Security Deposits SecurityDeposits	16000	usd
CY2022Q4	CCLD	Security Deposits SecurityDeposits	16000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30001000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35341000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30001000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35341000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14773000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4399000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1386000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	342000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-127000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	619000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8000	usd
CY2023Q1	CCLD	Increase Decrease In Deferred Revenue Long Term IncreaseDecreaseInDeferredRevenueLongTerm	8000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14646000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5018000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1394000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	350000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17006000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4725000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1085000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	341000	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1487000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-80000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	55000	usd
CY2022Q1	CCLD	Increase Decrease In Deferred Revenue Long Term IncreaseDecreaseInDeferredRevenueLongTerm	49000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18493000	usd
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4645000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1140000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	390000	usd
CY2023Q1	CCLD	Deferred Commissions DeferredCommissions	580000	usd
CY2022Q1	CCLD	Deferred Commissions DeferredCommissions	846000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	823000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	537000	usd
CY2023Q1	CCLD	Allowance For Doubtful Accounts Adoption AllowanceForDoubtfulAccountsAdoption	186000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	97000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	740000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	313000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	163000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	767000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	943000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	823000	usd
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	123000	usd
CY2023Q1	CCLD	Number Of Cashsetttled Awards NumberOfCashsetttledAwards	43597	shares
CY2023Q1	CCLD	Liability For Cash Settled Amount LiabilityForCashSettledAmount	246000	usd
CY2022Q4	CCLD	Liability For Cash Settled Amount LiabilityForCashSettledAmount	1000000.0	usd
CY2022Q1	CCLD	Cash Settlement CashSettlement	13000	usd
CY2023Q1	CCLD	Cash Settlement CashSettlement	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1072000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	887000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	65000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	39000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	26000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	36000	usd
CY2022Q4	CCLD	Deferred Tax Offset Liabilities DeferredTaxOffsetLiabilities	45000	usd
CY2022Q4	CCLD	Deferred Payroll Taxes Current DeferredPayrollTaxesCurrent	934000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30001000	usd
CY2023Q1	CCLD	Operating Costs OperatingCosts	18107000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2612000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5120000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1078000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3038000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	269000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	30224000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-223000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35341000	usd
CY2022Q1	CCLD	Operating Costs OperatingCosts	22673000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2384000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5585000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	985000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-600000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2940000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	158000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	34125000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1216000	usd

Files In Submission

Name	View Source	Status
ccld-20230331_lab.xml	Edgar Link	unprocessable
ccld-20230331_cal.xml	Edgar Link	unprocessable
ccld-20230331_def.xml	Edgar Link	unprocessable
0001493152-23-015456-index-headers.html	Edgar Link	pending
0001493152-23-015456-index.html	Edgar Link	pending
0001493152-23-015456.txt	Edgar Link	pending
0001493152-23-015456-xbrl.zip	Edgar Link	pending
ccld-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
ccld-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CCLD
CareCloud, Inc. Stock $ccld

2023 Q2 Form 10-Q Financial Statement

#000149315223015456 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCLD CareCloud, Inc. Stock $ccld

2023 Q2 Form 10-Q Financial Statement

#000149315223015456 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCLD
CareCloud, Inc. Stock $ccld